Clinical Trial

Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study is a multicenter RCT to compare 3-year overall survival(OS) rate, progression free survival(PFS),local progression free survival(LPFS),regional progression free survival(RPFS),distant metastasis free survival(DMFS), and toxicities of endonasal endoscopic surgery versus IMRT.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-12-31; most recent amendment 2021-02-20.
Trial Details
NCT Number NCT04215510
Lead Sponsor Eye & ENT Hospital of Fudan University
Collaborators: Chinese Academy of Medical Sciences, Shanghai Municipal Science and Technology Commission
Conditions Recurrent Nasopharyngeal Carcinoma
Enrollment 286 participants
Start Date 2021-03-01
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2021-02-23